These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26575119)
1. High Prolidase Levels may be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients? Tabur S; Sezen H; Korkmaz H; Ozkaya M; Akarsu E Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):82-6. PubMed ID: 26575119 [TBL] [Abstract][Full Text] [Related]
2. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata. Dizen-Namdar N; Emel Kocak F; Kidir M; Sarici G; Tak H; Altuntas I Skin Pharmacol Physiol; 2019; 32(2):59-64. PubMed ID: 30544126 [TBL] [Abstract][Full Text] [Related]
4. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
5. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350 [TBL] [Abstract][Full Text] [Related]
6. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy. Tabur S; Korkmaz H; Eren MA; Oğuz E; Sabuncu T; Aksoy N J Diabetes Complications; 2015; 29(1):115-9. PubMed ID: 25179234 [TBL] [Abstract][Full Text] [Related]
7. Decreased serum prolidase activity and increased oxidative stress in early pregnancy loss. Toy H; Camuzcuoglu H; Camuzcuoglu A; Celik H; Aksoy N Gynecol Obstet Invest; 2010; 69(2):122-7. PubMed ID: 19955811 [TBL] [Abstract][Full Text] [Related]
8. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. Toy H; Camuzcuoglu H; Arioz DT; Kurt S; Celik H; Aksoy N J Obstet Gynaecol Res; 2009 Dec; 35(6):1047-53. PubMed ID: 20144170 [TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia. Liang B; Li YH; Kong H Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonase and arylesterase activities in fibromyalgia. Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520 [TBL] [Abstract][Full Text] [Related]
11. Serum prolidase activity and oxidative-antioxidative status in patients with developmental dysplasia of the hip and its relationship with radiographic severity. Altay MA; Ertürk C; Levent A; Çetin BV; Aksoy N Redox Rep; 2017 Sep; 22(5):227-234. PubMed ID: 27320745 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase and arylesterase activities in patients with papillary thyroid cancer. Korkmaz H; Tabur S; Özkaya M; Aksoy N; Yildiz H; Akarsu E Scand J Clin Lab Invest; 2015 May; 75(3):259-64. PubMed ID: 25723374 [TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis. Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction. Aksoy S; Cam N; Gurkan U; Oz D; Özden K; Altay S; Durmus G; Agirbasli M Cardiol J; 2012; 19(4):381-6. PubMed ID: 22825899 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress markers in severe preeclampsia and preeclampsia-related perinatal morbidity - preliminary report. Oztas E; Ozler S; Tokmak A; Erel O; Ergin M; Uygur D; Danisman N Ginekol Pol; 2016; 87(6):436-41. PubMed ID: 27418221 [TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome. Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of prolidase activity and oxidative status in patients with knee osteoarthritis: relationships with radiographic severity and clinical parameters. Altay MA; Ertürk C; Bilge A; Yaptı M; Levent A; Aksoy N Rheumatol Int; 2015 Oct; 35(10):1725-31. PubMed ID: 25994092 [TBL] [Abstract][Full Text] [Related]
18. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease. Kirbas A; Kirbas S; Cure MC; Tufekci A J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052 [TBL] [Abstract][Full Text] [Related]
19. Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status. Korkmaz H; Tabur S; Ozkaya M; Oguz E; Aksoy N; Akarsu E J Endocrinol Invest; 2015 Nov; 38(11):1167-73. PubMed ID: 25900177 [TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp. Hao W; Zhu Y; Meng L; Ni C; Yang J; Zhou H Eur Arch Otorhinolaryngol; 2013 May; 270(6):1861-5. PubMed ID: 23238704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]